| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8736278 | Allergology International | 2018 | 6 Pages |
Abstract
Serum TARC levels correlate well with indicators of systemic inflammation and of disease severity among patients with a drug eruption except SJS/TEN. Serum TARC may be a prognostic biomarker of severity of inflammation in drug eruptions.
Keywords
SIRSNeutrophil to lymphocyte ratio (NLR)Maculopapular exanthemaThymus and activation-regulated chemokine (TARC)DIHSSJSNLRWBCALBMPEDBPSBPAlbuminerythema multiformethymus and activation-regulated chemokineBody temperaturetenGPSTARCStevens-Johnson syndromedrug-induced hypersensitivity syndromeSystemic inflammatory response syndromeSystemic inflammatory response syndrome (SIRS)diastolic blood pressuresystolic blood pressuredrug eruptionDRESSROC curvereceiver-operator characteristic curvePulse rateNeutrophil to lymphocyte ratioGlasgow Prognostic ScoreToxic epidermal necrolysisdrug reaction with eosinophilia and systemic symptomsC-reactive proteinCRPwhite blood cell
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
Takayoshi Komatsu-Fujii, Yuko Chinuki, Hiroyuki Niihara, Kenji Hayashida, Masataka Ohta, Ryota Okazaki, Sakae Kaneko, Eishin Morita,